Axcelis Technologies Valuation
Is ACLS * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ACLS * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ACLS * (MX$1780) is trading below our estimate of fair value (MX$3182.94)
Significantly Below Fair Value: ACLS * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ACLS *?
Other financial metrics that can be useful for relative valuation.
What is ACLS *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$3.38b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2.6x |
Enterprise Value/EBITDA | 10.8x |
PEG Ratio | 2.3x |
Price to Earnings Ratio vs Peers
How does ACLS *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 35.3x | ||
SEDG SolarEdge Technologies | 97x | 39.4% | US$3.4b |
SOI Soitec | 15.2x | 12.5% | €3.3b |
300724 Shenzhen S.C New Energy Technology | 12.8x | 19.8% | CN¥23.9b |
AIXA AIXTRON | 16.1x | 11.0% | €2.5b |
ACLS * Axcelis Technologies | 13.5x | 5.9% | Mex$3.4b |
Price-To-Earnings vs Peers: ACLS * is good value based on its Price-To-Earnings Ratio (13.5x) compared to the peer average (35.3x).
Price to Earnings Ratio vs Industry
How does ACLS *'s PE Ratio compare vs other companies in the Global Semiconductor Industry?
Price-To-Earnings vs Industry: ACLS * is good value based on its Price-To-Earnings Ratio (13.5x) compared to the Global Semiconductor industry average (32.5x).
Price to Earnings Ratio vs Fair Ratio
What is ACLS *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 13.5x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate ACLS *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$1,780.00 | Mex$2,677.03 +50.4% | 15.8% | Mex$3,081.31 | Mex$1,968.62 | n/a | 6 |
Apr ’25 | Mex$1,867.58 | Mex$2,728.78 +46.1% | 12.4% | Mex$3,075.32 | Mex$2,221.06 | n/a | 6 |
Mar ’25 | n/a | Mex$2,728.78 0% | 12.4% | Mex$3,075.32 | Mex$2,221.06 | n/a | 6 |
Feb ’25 | n/a | Mex$2,836.46 0% | 10.5% | Mex$3,087.14 | Mex$2,298.21 | n/a | 6 |
Jan ’25 | n/a | Mex$3,008.13 0% | 17.2% | Mex$3,699.94 | Mex$2,306.01 | n/a | 5 |
Dec ’24 | n/a | Mex$3,157.49 0% | 15.2% | Mex$3,754.76 | Mex$2,340.18 | n/a | 5 |
Nov ’24 | n/a | Mex$3,687.14 0% | 10.2% | Mex$4,096.82 | Mex$2,987.27 | n/a | 5 |
Oct ’24 | n/a | Mex$3,687.14 0% | 10.2% | Mex$4,096.82 | Mex$2,987.27 | n/a | 5 |
Sep ’24 | n/a | Mex$3,654.14 0% | 11.3% | Mex$4,102.90 | Mex$2,991.70 | n/a | 4 |
Aug ’24 | Mex$2,984.50 | Mex$2,745.05 -8.0% | 21.5% | Mex$3,766.07 | Mex$2,343.33 | n/a | 4 |
Jul ’24 | n/a | Mex$2,551.00 0% | 6.4% | Mex$2,824.93 | Mex$2,396.91 | n/a | 4 |
Jun ’24 | Mex$2,780.00 | Mex$2,617.11 -5.9% | 6.3% | Mex$2,933.58 | Mex$2,489.10 | n/a | 5 |
May ’24 | n/a | Mex$2,596.30 0% | 3.9% | Mex$2,786.88 | Mex$2,517.19 | Mex$1,780.00 | 5 |
Apr ’24 | n/a | Mex$2,666.05 0% | 3.8% | Mex$2,843.38 | Mex$2,568.22 | Mex$1,867.58 | 6 |
Mar ’24 | n/a | Mex$2,670.66 0% | 3.8% | Mex$2,848.30 | Mex$2,572.65 | n/a | 6 |
Feb ’24 | Mex$2,101.83 | Mex$2,020.56 -3.9% | 5.4% | Mex$2,167.58 | Mex$1,884.85 | n/a | 5 |
Jan ’24 | Mex$1,535.40 | Mex$1,735.72 +13.0% | 7.2% | Mex$1,856.91 | Mex$1,505.07 | n/a | 5 |
Dec ’23 | n/a | Mex$1,735.72 0% | 7.2% | Mex$1,856.91 | Mex$1,505.07 | n/a | 5 |
Nov ’23 | Mex$1,146.00 | Mex$1,710.25 +49.2% | 9.8% | Mex$1,902.50 | Mex$1,401.84 | n/a | 5 |
Oct ’23 | Mex$1,256.00 | Mex$1,814.92 +44.5% | 4.0% | Mex$1,898.87 | Mex$1,738.96 | n/a | 5 |
Sep ’23 | Mex$1,608.00 | Mex$1,860.20 +15.7% | 3.7% | Mex$1,938.42 | Mex$1,775.18 | n/a | 6 |
Aug ’23 | Mex$1,375.00 | Mex$1,696.34 +23.4% | 7.5% | Mex$1,945.51 | Mex$1,556.40 | Mex$2,984.50 | 6 |
Jul ’23 | Mex$1,161.00 | Mex$1,681.29 +44.8% | 7.5% | Mex$1,928.24 | Mex$1,542.59 | n/a | 6 |
Jun ’23 | Mex$1,212.12 | Mex$1,728.28 +42.6% | 9.5% | Mex$1,973.26 | Mex$1,530.28 | Mex$2,780.00 | 6 |
May ’23 | n/a | Mex$1,707.05 0% | 8.7% | Mex$1,975.88 | Mex$1,532.31 | n/a | 6 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.